Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
TC

Thomas Raymond Caferro — 6 Patents

Novartis Ag: 4 patents #1,111 of 5,128Top 25%
LILigand Pharmaceuticals Incorporated: 2 patents #82 of 191Top 45%
Abington, MA: #12 of 52 inventorsTop 25%
Massachusetts: #20,532 of 88,656 inventorsTop 25%
Overall (All Time): #779,687 of 4,157,543Top 20%
6 Patents All Time
Thomas Raymond Caferro has been granted 6 US patents while listed as an inventor at Novartis Ag. The first was granted in 2002 and the most recent in October 2018. Thomas Raymond Caferro ranks #779,687 of 4,157,543 US inventors in our database (top 18.8%). Patent records list Thomas Raymond Caferro in Abington, MA, US.

Patents per Year

Patents granted per year, 2002 to 2018Bar chart with a peak of 1 patents in 2002.peak 12002: 1 patents20022007: 1 patents20072015: 1 patents20152016: 1 patents20162017: 1 patents20172018: 1 patents2018

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
10112931 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH Zhuoliang Chen, Young Shin Cho, Abran Q. Costales, Julian Levell, Gang Liu +7 more 2018-10-30 $10,292,000
9688672 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH Zhuoliang Chen, Young Shin Cho, Abran Q. Costales, Julian Levell, Gang Liu +7 more 2017-06-27 $19,167,000
9434719 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH Zhuoliang Chen, Young Shin Cho, Abran Q. Costales, Julian Levell, Gang Liu +7 more 2016-09-06 $37,307,000
8957068 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH Young Shin Cho, Abran Q. Costales, Huangshu Lei, Francois Lenoir, Julian Levell +11 more 2015-02-17 $25,648,000
7214690 Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods Robert I. Higuchi, Lin Zhi, Donald S. Karanewsky, Anthony W. Thompson, Neelakandha S. Mani +5 more 2007-05-08 $1,709,000
6462038 Androgen receptor modulator compounds and methods Robert I. Higuchi, Kristen L. Arienti, Mani Neelakandha, Barbara Pio, Lin Zhi +1 more 2002-10-08 $8,490,000